Guidelines for the diagnosis and treatment of malignant pleural mesothelioma - PMC Back to
Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …

This review addresses the management of MPM. In an introductory section, the etiology,
epidemiology, presentation, diagnosis and staging of MPM will be reviewed. The evidence …

Purpose To provide evidence-based recommendations to practicing physicians and others
on the management of malignant pleural mesothelioma. Methods ASCO convened an …

Background The use of prophylactic radiotherapy to prevent procedure-tract metastases
(PTMs) in malignant pleural mesothelioma remains controversial, and clinical practice varies …

Malignant pleural mesothelioma (MPM) is a rapidly progressive invariabe lethal tumor.
Treatment options remain limited and the outcome in relapsed disease is poor warranting …

PURPOSE Prophylactic irradiation to the chest wall after diagnostic or therapeutic
procedures in patients with malignant pleural mesothelioma (MPM) has been a widespread …

Malignant pleural mesothelioma (MPM) represents a significant diagnostic and therapeutic
challenge and is almost always a fatal disease. Imaging abnormalities are common, but …

Mesothelioma is a type of late‐onset cancer that develops in cells covering the outer surface
of organs. Although it can affect the peritoneum, heart, or testicles, it mainly targets the lining …

Malignant pleural mesothelioma (MPM) is a rare, but severe form of cancer, with an
incidence that varies significantly within and among different countries around the world. It …

Malignant pleural mesothelioma (MPM) is a relevant public health issue. A large amount of
data indicate a relationship between mesothelioma and asbestos exposure. MPM incidence …